377740 — Bionote Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareAdventurousSmall CapSuper Stock

Annual balance sheet for Bionote, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

	2020 December 31st	R2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	—	—	—	—	—
Source:	PROSPECTUS	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Cash
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	203,610	488,612	720,789	399,985	414,824
Net Total Accounts Receivable
Net Total Receivables	310,664	84,079	18,304	24,864	25,085
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	573,428	640,709	824,836	456,478	465,700
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	49,659	98,007	97,159	89,594	92,635
Net Goodwill
Net Intangible Assets
Long Term Investments
Long Term Notes Receivable
Other Long Term Assets
Total Assets	853,440	1,488,867	1,757,002	1,592,842	1,697,157
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	183,912	118,273	49,505	10,801	23,656
Capital Lease Obligations
Total Long Term Debt
Total Debt
Deferred Income Tax
Total Other Liabilities
Total Liabilities	214,744	216,363	156,850	36,266	61,384
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	638,696	1,272,504	1,600,152	1,556,576	1,635,773
Total Liabilities & Shareholders' Equity	853,440	1,488,867	1,757,002	1,592,842	1,697,157
Total Common Shares Outstanding